Skip to main content
SpringerLink
Log in

Calcium Channel Blockers

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wellens HJ, Tan SL, Bar FW, Duren DR, Lie KI, Dohmen HM. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J 1977:39: 1058-1066.

    Google Scholar 

  2. Shenasa M, Fromer M, Faugere G, Nadeau R, Leblanc RA, Lambert C, Sadr-Ameli MA. Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome. Am J Cardiol 1987;59:301-306.

    Google Scholar 

  3. Rizos I, Seidl KH, Aidonidis I, Stamou S, Senges J, Toutouzas P. Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia. Cardiology 1994;85:388-396.

    Google Scholar 

  4. Yeh SJ, Kow HC, Lin FC, Hung JS, Wu D. Effects of oral diltiazem in paroxysmal supraventricular tachycardia. AmJ Cardiol 1983;52:271-278.

    Google Scholar 

  5. Tonkin AM, Aylward PE, Joel SE, Heddle WF. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia. J Cardiovasc Pharmacol 1980;2:473-486.

    Google Scholar 

  6. Klein HO, Pauzner H, Di Segni E, David D, Kaplinsky E. The beneficial effects of verapamil in chronic atrial fibrillation. Arch Intern Med 1979;139:747-749.

    Google Scholar 

  7. Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. Int J Cardiol 1995;52:167-174.

    Google Scholar 

  8. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, Raviele A, Lolli G, Paparella N, Accquarone S. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study. Circulation 1997;96:2617-2624.

    Google Scholar 

  9. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988;62:403-407.

    Google Scholar 

  10. Wijffels MC, Kirchof CJ, Dorland R, Allessie MA. AFbegets AF: A study in awake chronically instrumented goals. Circulation 1995;92:1954-1968.

    Google Scholar 

  11. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.

    Google Scholar 

  12. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Stickberger SA, Morady F. Effect of atrial fibrillation of atrial refractoriness in humans. Circulation 1996;94:1600-1606.

    Google Scholar 

  13. Tieleman RF, DeLangen C, Van Gelder IC, deKam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia-induced electrical remodeling of the atrial. Circulation 1997;95:1945-1953.

    Google Scholar 

  14. Daoud EF, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, Man KC, Strickberger SA, Morady F. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-1550.

    Google Scholar 

  15. Tieleman RG, Van Gelder IC, Crijns HJ, DeKam PJ, Van Den Berg MP, Haaksma J, Van DerWoude HJ, Allessie MA. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria. J Am Coll Cardiol 1998;31:167-173.

    Google Scholar 

  16. Timmermans C, Rodriguez LM, Smeets JL, Wellens H. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998;9: 122-128.

    Google Scholar 

  17. Wellens HJ. Value and limitation of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 1978;57:845-853.

    Google Scholar 

  18. Vaage-Nilsen M, Hansen JF, Mellemgaard K, Hagerup L, Sigurd B, Steinmetz E. Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II). Int J Cardiol 1995;48:255-258.

    Google Scholar 

  19. Lee SH, Chen SA, Tai CT, Chiang CE, Wu TJ, Cheng CC, Chiou CW, Ueng KC, Wang SP, Chiang BN, Chang MS. Electropharmacologic characteristics and radiofrequency catheter ablation of sustained ventricular tachycardia in patients without structural heart disease. Cardiology 1996; 87:33-41.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Calgary/Calgary Regional Health Authority, Calgary, Alberta, Canada

    D. George Wyse

Authors
  1. D. George Wyse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wyse, D.G. Calcium Channel Blockers. Card Electrophysiol Rev 2, 218–221 (1998). https://doi.org/10.1023/A:1009996420245

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009996420245

Keywords

Search

Navigation